Cargando…

microRNA Expression Profiling in Young Prostate Cancer Patients

MicroRNAs (miRNAs) are small, non-coding RNA molecules with multiple roles in many biological processes. Few studies have shown the molecular characteristics in younger prostate cancer (PCa) patients. In this study, we performed miRNA profiling in young PCa (EO-PCa) cases compared with PCa arising i...

Descripción completa

Detalles Bibliográficos
Autores principales: Valera, Vladimir A., Parra-Medina, Rafael, Walter, Beatriz A., Pinto, Peter, Merino, Maria J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7196262/
https://www.ncbi.nlm.nih.gov/pubmed/32368293
http://dx.doi.org/10.7150/jca.37842
_version_ 1783528689754963968
author Valera, Vladimir A.
Parra-Medina, Rafael
Walter, Beatriz A.
Pinto, Peter
Merino, Maria J
author_facet Valera, Vladimir A.
Parra-Medina, Rafael
Walter, Beatriz A.
Pinto, Peter
Merino, Maria J
author_sort Valera, Vladimir A.
collection PubMed
description MicroRNAs (miRNAs) are small, non-coding RNA molecules with multiple roles in many biological processes. Few studies have shown the molecular characteristics in younger prostate cancer (PCa) patients. In this study, we performed miRNA profiling in young PCa (EO-PCa) cases compared with PCa arising in older men (LO-PCa). Experimental Design: Formalin-fixed, paraffin embedded tissue was used. miRNA was extracted for PCR array and NanoString methods. Relative miRNAs expression levels were obtained by comparing young vs older men, and young PCa tumor samples vs normal epithelium. Results: miRNA profiling showed a different expression pattern in PCa arising in younger men, and young PCa tumoral and its normal counterpart. Nine miRNAs (hsa-miR-140-5p, hsa-miR-146a, hsa-miR-29b, hsa-miR-9, hsa-miR-124-3p, hsa-let-7f-5p, hsa-miR-184, hsa-miR-373, hsa-miR-146b-5p) showed differences in the expression compared to LO-PCa. Fourteen miRNAs were significantly up-regulated (miR-1973, miR-663a, miR-575, miR-93-5p, miR-630, miR-600, miR-494, miR-150-5p, miR-137, miR-25-3p, miR-375, miR-489, miR-888-5p, miR-142-3p), while 9 were found down-regulated (miR-21-5p, miR-363-3p, miR-205-5p, miR-548ai, miR-3195, 145-5p, miR-143-3p, miR-222-3p, miR-221-3p) comparing young PCa tumoral tissue compared to normal counterpart. The higher expression of miR-600 and miR-137 were associated with high Gleason score, extraprostatic extension and lymphatic invasion. Conclusion: These results suggest that PCa in younger patients has a different expression profile compared to normal tissue and PCa arising in older man. Differentially expressed miRNAs provide insights of molecular mechanisms involve in this PCa subtype.
format Online
Article
Text
id pubmed-7196262
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Ivyspring International Publisher
record_format MEDLINE/PubMed
spelling pubmed-71962622020-05-04 microRNA Expression Profiling in Young Prostate Cancer Patients Valera, Vladimir A. Parra-Medina, Rafael Walter, Beatriz A. Pinto, Peter Merino, Maria J J Cancer Research Paper MicroRNAs (miRNAs) are small, non-coding RNA molecules with multiple roles in many biological processes. Few studies have shown the molecular characteristics in younger prostate cancer (PCa) patients. In this study, we performed miRNA profiling in young PCa (EO-PCa) cases compared with PCa arising in older men (LO-PCa). Experimental Design: Formalin-fixed, paraffin embedded tissue was used. miRNA was extracted for PCR array and NanoString methods. Relative miRNAs expression levels were obtained by comparing young vs older men, and young PCa tumor samples vs normal epithelium. Results: miRNA profiling showed a different expression pattern in PCa arising in younger men, and young PCa tumoral and its normal counterpart. Nine miRNAs (hsa-miR-140-5p, hsa-miR-146a, hsa-miR-29b, hsa-miR-9, hsa-miR-124-3p, hsa-let-7f-5p, hsa-miR-184, hsa-miR-373, hsa-miR-146b-5p) showed differences in the expression compared to LO-PCa. Fourteen miRNAs were significantly up-regulated (miR-1973, miR-663a, miR-575, miR-93-5p, miR-630, miR-600, miR-494, miR-150-5p, miR-137, miR-25-3p, miR-375, miR-489, miR-888-5p, miR-142-3p), while 9 were found down-regulated (miR-21-5p, miR-363-3p, miR-205-5p, miR-548ai, miR-3195, 145-5p, miR-143-3p, miR-222-3p, miR-221-3p) comparing young PCa tumoral tissue compared to normal counterpart. The higher expression of miR-600 and miR-137 were associated with high Gleason score, extraprostatic extension and lymphatic invasion. Conclusion: These results suggest that PCa in younger patients has a different expression profile compared to normal tissue and PCa arising in older man. Differentially expressed miRNAs provide insights of molecular mechanisms involve in this PCa subtype. Ivyspring International Publisher 2020-04-07 /pmc/articles/PMC7196262/ /pubmed/32368293 http://dx.doi.org/10.7150/jca.37842 Text en © The author(s) This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
spellingShingle Research Paper
Valera, Vladimir A.
Parra-Medina, Rafael
Walter, Beatriz A.
Pinto, Peter
Merino, Maria J
microRNA Expression Profiling in Young Prostate Cancer Patients
title microRNA Expression Profiling in Young Prostate Cancer Patients
title_full microRNA Expression Profiling in Young Prostate Cancer Patients
title_fullStr microRNA Expression Profiling in Young Prostate Cancer Patients
title_full_unstemmed microRNA Expression Profiling in Young Prostate Cancer Patients
title_short microRNA Expression Profiling in Young Prostate Cancer Patients
title_sort microrna expression profiling in young prostate cancer patients
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7196262/
https://www.ncbi.nlm.nih.gov/pubmed/32368293
http://dx.doi.org/10.7150/jca.37842
work_keys_str_mv AT valeravladimira micrornaexpressionprofilinginyoungprostatecancerpatients
AT parramedinarafael micrornaexpressionprofilinginyoungprostatecancerpatients
AT walterbeatriza micrornaexpressionprofilinginyoungprostatecancerpatients
AT pintopeter micrornaexpressionprofilinginyoungprostatecancerpatients
AT merinomariaj micrornaexpressionprofilinginyoungprostatecancerpatients